Jmac Enterprises LLC Pfizer Inc Transaction History

Jmac Enterprises LLC

$610 Million
Q3 2024

A detailed history of Jmac Enterprises LLC transactions in Pfizer Inc stock. As of the latest transaction made, Jmac Enterprises LLC holds 47,466 shares of PFE stock, worth $1.25 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

47,466

Previous 48,504 2.14%

Holding current value

$1.25 Million

Previous $1.36 Million 1.18%

% of portfolio

0.23%

Previous 0.24%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $28,752 - $32,582	-1,038 Reduced 2.14%	47,466 $1.37 Million
Q2 2024 Jul 30, 2024	BUY	$25.26 - $29.6 $41,451 - $48,573	1,641 Added 3.5%	48,504 $1.36 Million
Q1 2024 Apr 30, 2024	SELL	$25.89 - $29.73 $98,589 - $113,211	-3,808 Reduced 7.52%	46,863 $1.3 Million
Q4 2023 Jan 26, 2024	SELL	$26.13 - $33.94 $341,780 - $443,935	-13,080 Reduced 20.52%	50,671 $1.46 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $12,964 - $15,154	-404 Reduced 0.63%	63,751 $2.11 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $134,149 - $155,208	3,714 Added 6.14%	64,155 $2.35 Million
Q1 2023 Apr 20, 2023	BUY	$39.39 - $51.28 $518,411 - $674,896	13,161 Added 27.84%	60,441 $2.47 Million
Q4 2022 Jan 23, 2023	BUY	$41.75 - $54.5 $70,933 - $92,595	1,699 Added 3.73%	47,280 $0
Q3 2022 Oct 20, 2022	BUY	$43.76 - $53.42 $8,401 - $10,256	192 Added 0.42%	45,581 $1.99 Million
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $17,541 - $20,799	377 Added 0.84%	45,389 $2.38 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $18,528 - $22,959	-405 Reduced 0.89%	45,012 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.88 Million - $2.78 Million	45,417 New	45,417 $2.32 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jmac Enterprises LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jmac Enterprises LLC with notifications on news.

Account

Jmac Enterprises LLC Pfizer Inc Transaction History